Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practiceAnna Maria Frustaci, Lara Crucitti, Claudia Baratè et al.|Haematologica|2025Cited by 2
Real-World Venetoclax-Obinutuzumab in 232 Treatment Naive CLL Patients: Feasibility and TolerabilityAlessandra Tedeschi, Luca Laurenti, Andrea Galitzia et al.|Blood|2023Cited by 1
Baseline Characteristics from CLL-ZANU2024, an Italian Non-Interventional Study Assessing the Real-World Use of Zanubrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)Enrica Antonia Martino, Federico Vozzella, Raffaella Pasquale et al.|Blood|2024Cited by 0